Relevant bibliographies by topics / Bible. N.T. John III, 1-12

Contents

  1. Journal articles
  2. Books

Academic literature on the topic 'Bible. N.T. John III, 1-12'

Author: Grafiati
Published: 26 July 2024
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Bible. N.T. John III, 1-12.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Bible. N.T. John III, 1-12"

1

Silvianti, Fitrilia, Dwi Siswanta, Nurul Hidayat Aprilita, and Agung Abadi Kiswandono. "ADSORPTION CHARACTERISTIC OF IRON ONTO POLY[EUGENOL-CO-(DIVINYL BENZENE)] FROM AQUEOUS SOLUTION." Jurnal Natural 17, no. 2 (2017): 108. http://dx.doi.org/10.24815/jn.v17i2.8076.

Full text
Abstract:
A study on the adsorption characteristic of Iron onto Poly[eugenol-co-(divinyl benzene)] (EDVB) from aqueous solution has been conducted. EDVB was produced and characterized by using FTIR spectroscopy. The adsorption was studied by a batch method by considering the factors affecting the adsorption such as initial metal ion concentration, adsorption selectivity, and mechanism of adsorption using a sequential desorption method. The adsorption of Iron onto EDVB followed a pseudo-2 order kinetics model with the rate constant of 0,144 L2 mmol-1 min-1. The adsorption isotherm was studied with Tempki
APA, Harvard, Vancouver, ISO, and other styles
2

Kumar, Shaji K., Jin Lu, Yang Terry Liu, et al. "Outcomes of Patients with t(11;14) Multiple Myeloma: An International Myeloma Working Group Multicenter Study." Blood 134, Supplement_1 (2019): 3066. http://dx.doi.org/10.1182/blood-2019-126867.

Full text
Abstract:
Background: Multiple myeloma (MM) is a heterogeneous disease with varying survival outcomes depending on the presence of certain genetic abnormalities. Common abnormalities include trisomies, translocations involving the chromosome 14, and amplifications or deletions of chromosomes 1, 13, and 17. t(11;14), occurring in 15% of patients with myeloma, had been considered a standard risk abnormality, but recent data suggest inferior outcome. This is important as new therapeutic options such as the BCL-2 inhibitor venetoclax has been shown to be particularly effective in t(11;14) patients. Methods:
APA, Harvard, Vancouver, ISO, and other styles
3

Amoozgar, Behzad, Ayrton I. Bangolo, David H. Vesole, et al. "Comparative Efficacy and Safety of Ciltacabtagene Autoleucel and Idecabtagene Vicleucel in Real-World Relapsed/Refractory Multiple Myeloma: A Retrospective Intention-to-Treat Analysis." Blood 144, Supplement 1 (2024): 2408. https://doi.org/10.1182/blood-2024-211671.

Full text
Abstract:
Introduction Chimeric Antigen Receptor T-cell (CAR-T) therapy has emerged as a major advancement in the therapeutic landscape for relapsed/refractory multiple myeloma (R/R MM). Carvykti (ciltacabtagene autoleucel) and Abecma (idecabtagene vicleucel), both targeting B-cell maturation antigen (BCMA), have shown promising results in clinical trials. However, real-world comparative data remains limited. This study aims to compare the clinical outcomes and safety profiles of Carvykti and Abecma in R/R MM patients outside of controlled clinical trial settings. Methods A retrospective cohort study wa
APA, Harvard, Vancouver, ISO, and other styles
4

Sirvén, Milana Bergamino, Xixuan Zhu, Elena López-Knowles, et al. "Abstract P1-11-14: Hormone receptor positive (ER+) HER2+ Lobular Breast Carcinoma: Molecular Response to Perioperative Endocrine Therapy and Clinical Outcomes in the POETIC Trial." Clinical Cancer Research 31, no. 12_Supplement (2025): P1–11–14—P1–11–14. https://doi.org/10.1158/1557-3265.sabcs24-p1-11-14.

Full text
Abstract:
Abstract Background: Invasive Lobular Carcinoma (ILC) represents about 15% of all invasive breast cancers (BC). ILC seldom exhibits overexpression of human epidermal growth factor 2 (HER2+), and majority of research focuses on ER+ HER2-negative phenotypes. There is limited data on response of ER+HER2+ ILC to endocrine therapy (ET) and the therapeutic efficacy of combined chemotherapy and anti-HER2 treatments (C+T). This study aims to report the biological responsiveness of ER+HER2+ ILC to perioperative aromatase inhibitors (POAI) and their clinical outcome within POETIC trial, one of the most
APA, Harvard, Vancouver, ISO, and other styles
5

Klink, Edward W. "The Beginning and End of All Things: A Biblical Theology of Creation and New Creation." Perspectives on Science and Christian Faith 76, no. 3 (2024): 231–32. https://doi.org/10.56315/pscf12-24klink.

Full text
Abstract:
THE BEGINNING AND END OF ALL THINGS: A Biblical Theology of Creation and New Creation by Edward W. Klink III. Downers Grove, IL: IVP Academic, 2023. 208 pages, including discussion questions and in-dices. Paperback; $24.00. ISBN: 9780830855223. *Whereas many people tend to associate the doctrine of creation with the origins of the world, Edward Klink is concerned to form a theology of creation that envelops all of scripture. Klink is senior pastor of Hope Church, Roscoe, IL, and formerly on the faculty of Talbot School of Theology, Biola University. *Throughout the introduction and ten chapter
APA, Harvard, Vancouver, ISO, and other styles
6

Wildenboer, Johan. "JOSHUA 24: SOME LITERARY AND THEOLOGICAL REMARKS." Journal for Semitics 24, no. 2 (2017): 484–502. http://dx.doi.org/10.25159/1013-8471/3465.

Full text
Abstract:
Achenbach, R 2005. Pentateuch, Hexateuch und Enneateuch. Eine Verhältnisbestimmung, ZAR 11:122–154. Albertz, R 2007. Die kanonische Anpassung des Johuabuches. Ein Neubewertung seiner sog.”Priesterschriftelike Texte”, in Römer and Schmid 2007:199–217. Aurelius, E 2003. Zukunft jenseits des Gerichts: Eine redaktionsgeschichltliche Studie zumEnneateuch. BZAW 319. Berlin: de Gruyter. Barrick, W B & Spencer, J R (eds) 1984. In the shelter of Elyon: essays on ancient Palestinian life in honour of GW Ahlström. JSOTSup 31. Sheffield: JSOT Press. Becker U, 2006. Endredaktionelle Kontextvernetzungen
APA, Harvard, Vancouver, ISO, and other styles
7

Hapidin, Erie Siti Syarah, Yuli Pujianti, and Winda Gunarti. "Instilling Children's Ocean Literacy Through Comic Media: STEAM to R-SLAMET Learning Design for ECE educators." JPUD - Jurnal Pendidikan Usia Dini 16, no. 1 (2022): 01–16. http://dx.doi.org/10.21009/jpud.161.01.

Full text
Abstract:
Ocean literacy is currently at the forefront of the development of the notion of marine environmental sustainability. It is critical to compare ocean literacy ideas in curriculum standards. Comics Convey various messages of maritime insight content on integrated, contextual, and meaningful learning. This study aims to design STEAM (to R-SLAMET; Religion, Science, Literacy, Art, Math, Engineer, and Technology) learning that contains ocean literacy messages in a comic media. Through the qualitative research method with study case type, researchers seek to aid early childhood education (ECE) educ
APA, Harvard, Vancouver, ISO, and other styles
8

Chapman, Judith-Anne, Jane Bayani, Sandip SenGupta, et al. "Abstract P1-07-06: Adjunctive statistical standardization of quantitated adjuvant HER2 and very low statistically standardized HER2 in CCTG MA.27." Clinical Cancer Research 31, no. 12_Supplement (2025): P1–07–06—P1–07–06. https://doi.org/10.1158/1557-3265.sabcs24-p1-07-06.

Full text
Abstract:
Abstract Background: We proposed adjunctive statistical standardization of quantitated ER and PgR to improve inter-laboratory comparability of biomarker results and therapeutic management of breast cancer. Adjunctive statistical standardization of quantitated HER2 is used here; we also examined the effects on outcome of ultra-low HER2 and very low statistically standardized HER2. Methods: We utilized CCTG MA.27 (NCT00066573), an adjuvant phase III trial of exemestane versus anastrozole in postmenopausal women with ER+ and/or PgR+ tumors. IHC HER2 HSCORE and % positivity (%+) were centrally ass
APA, Harvard, Vancouver, ISO, and other styles
9

Swapna, Kandagatla, M. Srujana, and Mamidala Estari. "Identification of terpenoids from Withania somnifera as a HIV-1 entry inhibitors that prevent gp120 binding to CD4 using In Silico Approach." High Technology Letters 28, no. 12 (2022): 973–81. https://doi.org/10.5281/zenodo.7479434.

Full text
Abstract:
<strong>Introduction</strong> Human immunodeficiency virus (HIV-1), the most prevalent and pathogenic type of the virus, is what causes acquired immunodeficiency syndrome (AIDS). Approximately 30 anti-HIV-1 medications have been applied to the management of AIDS. However, effective anti HIV-1 agents with less side affect and high inhibition potency are still in demand. The objective of this study was to identify the potential terpenoid compounds from <em>Withania somnifera</em> plant that might be active as anti-HIV-1 gp120 by molecular docking that inhibits viral attachment and entry for the
APA, Harvard, Vancouver, ISO, and other styles
10

Howlett, Christina, Andre Goy, Tania Zielonka, et al. "Dose Intensive Induction Followed By Allogeneic Stem Cell Transplantation More Than Doubles Progression-Free and Overall Survival In “Double-Hit” Lymphoma (DHL)." Blood 122, no. 21 (2013): 2141. http://dx.doi.org/10.1182/blood.v122.21.2141.2141.

Full text
Abstract:
Abstract Introduction There is a growing awareness of the molecular heterogeneity of DLBCL beyond the GC and non-GC well established subtypes. “Double-hit” lymphoma (DHL) harboring rearrangements of c-Myc and BCL2 have been clearly associated with a poor prognosis. It is well recognized that these pts do poorly with R-CHOP and typically cannot be salvaged using ASCT in the relapse setting. Small series suggest that dose-intensive (DI) strategies may lead to better outcomes in the frontline setting and that some pts achieve durable disease control after allogeneic SCT in the relapse setting. We
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Bible. N.T. John III, 1-12"

1

Kysar, Robert. 1, 2, 3 John. Augsburg Pub. House, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wiersbe, Warren W. Be alive: Get to know the Living Savior : NT commentary, John 1-12. 2nd ed. David C. Cook, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wiersbe, Warren W. Be alive: Get to know the Living Savior : NT commentary, John 1-12. 2nd ed. David C. Cook, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Brestin, Dee. How should a Christian live?: 1, 2, 3 John : 12 studies for individuals or groups. Harold Shaw Publishers, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sharp, Daniel B. Papyrus Bodmer III : An Early Coptic Version of the Gospel of John and Genesis 1-4: 2. De Gruyter, Inc., 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Papyrus Bodmer III : An Early Coptic Version of the Gospel of John and Genesis 1-4: 2. Walter de Gruyter Inc., 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Farmer, Craig S. John 1-12. InterVarsity Press, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Palmer, Earl. Communicator's Commentary Vol. 12: 1, 2, 3 John and Revelations. Nelson Incorporated, Thomas, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Essays in the Judaic Background of Mark 11 : 12-14, 20-21; 15 : 23; Luke 1 : 37; John 19 : 28-30; and Acts 11: 28. University Press of America, Incorporated, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Beginnings: Keys that open the Gospels. Trinity Press International, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Bible. N.T. John III, 1-12' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography